Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10326
Telos
TLS
$333M
| $210K | ﹤0.01% |
61,462
+39,428
| +179% | +$141K |
2021 Q3
13 quarters
|
|
|
FBCV
10327
Fidelity Blue Chip Value ETF
FBCV
$188M
| $210K | ﹤0.01% |
+6,648
| New | +$218K |
2024 Q4
0 quarters
|
|
10328
Gaotu Techedu
GOTU
$656M
| $210K | ﹤0.01% |
95,934
-70,013
| -42% | -$204K |
2021 Q3
13 quarters
|
|
|
AIOS
10329
AIOS Tech
AIOS
$36.3M
| $210K | ﹤0.01% |
+1,565
| New | +$301K |
2024 Q4
0 quarters
|
|
10330
CALL
Kodiak Sciences
KOD
$6.2B
| $210K | ﹤0.01% |
21,100
+14,600
| +225% | +$83.9K |
2019 Q4
20 quarters
|
|
10331
PUT
Vir Biotechnology
VIR
$1.97B
| $210K | ﹤0.01% |
28,600
+19,000
| +198% | +$150K |
2020 Q2
18 quarters
|
|
10332
ProShares Short High Yield
SJB
$52.6M
| $210K | ﹤0.01% |
+12,996
| New | +$212K |
2024 Q4
0 quarters
|
|
10333
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.33B
| $210K | ﹤0.01% |
+17,113
| New | +$221K |
2024 Q4
0 quarters
|
|
10334
CALL
HCI Group
HCI
$2.4B
| $210K | ﹤0.01% |
+1,800
| New | +$205K |
2024 Q4
0 quarters
|
|
|
HOS
10335
CALL
Hornbeck Offshore Services, Inc.
HOS
$2.5B
| $210K | ﹤0.01% |
22,500
-66,400
| -75% | -$668K |
2020 Q2
18 quarters
|
|
|
AJUL
10336
Innovator Equity Defined Protection ETF - 2 Yr to July 2028
AJUL
$98.8M
| $210K | ﹤0.01% |
+7,760
| New | +$209K |
2024 Q4
0 quarters
|
|
10337
PUT
Knowles
KN
$3.2B
| $209K | ﹤0.01% |
10,500
+10,300
| +5,150% | +$192K |
2022 Q4
8 quarters
|
|
10338
ProShares Ultra Health Care
RXL
$96.5M
| $209K | ﹤0.01% |
4,756
-2,766
| -37% | -$139K |
2024 Q3
1 quarter
|
|
|
IRD
10339
Opus Genetics
IRD
$384M
| $209K | ﹤0.01% |
175,773
+88,954
| +102% | +$102K |
2023 Q4
4 quarters
|
|
10340
Innovator US Equity Ultra Buffer ETF September
USEP
$237M
| $209K | ﹤0.01% |
5,943
-5,480
| -48% | -$192K |
2024 Q2
2 quarters
|
|
10341
CALL
Peoples Bancorp
PEBO
$1.29B
| $209K | ﹤0.01% |
6,600
+3,100
| +89% | +$102K |
2022 Q4
8 quarters
|
|
10342
Avita Medical
RCEL
$409M
| $209K | ﹤0.01% |
16,319
-14,563
| -47% | -$172K |
2022 Q2
10 quarters
|
|
|
KG
10343
Kestrel Group
KG
$39M
| $209K | ﹤0.01% |
6,176
+3,470
| +128% | +$111K |
2024 Q3
1 quarter
|
|
10344
Hanover Bancorp
HNVR
$174M
| $209K | ﹤0.01% |
+9,053
| New | +$198K |
2024 Q4
0 quarters
|
|
10345
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$142M
| $209K | ﹤0.01% |
2,241
-44,758
| -95% | -$4.26M |
2023 Q3
5 quarters
|
|
10346
Flux Power
FLUX
$10.2M
| $209K | ﹤0.01% |
131,967
+115,355
| +694% | +$274K |
2021 Q4
12 quarters
|
|
10347
State Street SPDR S&P Kensho Intelligent Structures ETF
SIMS
$8.05M
| $208K | ﹤0.01% |
+6,099
| New | +$218K |
2024 Q4
0 quarters
|
|
|
NVRO
10348
PUT
DELISTED
NEVRO CORP.
NVRO
| $208K | ﹤0.01% |
56,000
-41,400
| -43% | -$191K |
2015 Q3
37 quarters
|
|
10349
PUT
Similarweb
SMWB
$777M
| $208K | ﹤0.01% |
14,700
+2,100
| +17% | +$23.2K |
2023 Q4
4 quarters
|
|
10350
iShares LifePath Target Date 2035 ETF
ITDC
$120M
| $208K | ﹤0.01% |
+6,977
| New | +$215K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.